Aegle marmelos fruit extract attenuates Helicobacter pylori Lipopolysaccharide induced oxidative stress in Sprague Dawley rats

BMC Complementary and Alternative Medicine

Sivasitamparam Niranjali Devaraj¹  Manfred Kist²  Kumarasamy Savithri¹  Yarasi Gayathri Ramakrishna¹ 

[1] Department of Biochemistry, University of Madras, Guindy Campus, Chennai 600025, India;Institut fur Medizinische, Mekrobiologie und Hygiene, Freiburg, Germany

关键词: Gastric ulcer;    Antioxidants;    Aegle marmelos;    Helicobacter pylori lipopolysaccharide;   

Others  :  1233224
DOI  :  10.1186/s12906-015-0915-x

 received in 2015-02-02, accepted in 2015-10-13,  发布年份 2015

【 摘 要 】

Background

Bael (Aegle marmelos (L.) Corr.) has been widely used in indigenous systems of Indian medicine to exploit its medicinal properties including astringent, antidiarrheal, antidysenteric, demulcent, antipyretic, antiulcer, anti-inflammatory and anti cancer activities. The present study aims to evaluate the antioxidative and antiulcer effect of methanolic extract of unripe fruit of Aegle marmelos (MEAM) against Helicobacter pylori-Lipopolysaccharide (HP-LPS) induced gastric ulcer in Sprague Dawley (SD) rats.

Methods

Dose and duration of HP-LPS and MEAM were fixed based on ulcer index of gastric tissue of experimental animals. Various gastric secretory parameters such as volume of gastric juice, free and total acidity, acid output, pepsin concentration were analyzed. The activities of enzymatic antioxidants (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and glutathione transferase), non-enzymatic antioxidants (reduced glutathione, vitamin C and vitamin E) and the levels of lipid peroxidation products were measured. Histological analysis was performed to evaluate the effect of Aegle marmelos on HP-LPS induced gastric ulcer.

Results

Oral administration of HP-LPS (50 μg per animal) for four consecutive days resulted in induction of ulcer with the increase in gastric secretory parameters such as volume of gastric juice, free and total acidity, acid output, pepsin concentration. Oral administration of methanolic extract of Aegle marmelos fruit (MEAM) (25, 50, 100, 250 and 500 mg/kg) reduced the gastric ulcer by 2.8 %, 52.4 %, 73 %, 93 % and 93.98 %, respectively, compared to 89.2 % reduction by sucralfate (100 mg/kg). MEAM treatment significantly (p < 0.05) inhibited the increase in gastric secretory parameters in ulcerated rats, and it also prevented the reduction of enzymatic (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and glutathione transferase) and non-enzymatic antioxidants (reduced glutathione, vitamin C and vitamin E) after HP-LPS induction. In addition, lipid peroxidation was inhibited by MEAM in HP-LPS induced rats. Results of histological analysis correlated well with biochemical parameters.

Conclusion

These observations explored the antioxidant properties of MEAM contributing to the gastroprotective effect in HP-LPS induced gastric ulcer model.

【 授权许可】

   
2015 Ramakrishna et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

【 参考文献 】

• [1]Falush D, Wirth T, Linz B, Pritchard JK, Stephens M, Kidd M et al.. Traces of human migration in Helicobacter pylori populations. Science. 2003; 299:1582-1585.
• [2]Cover TL, Blaser MJ. Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. Adv Intern Med. 1999; 41:85-117.
• [3]Parsonnet J. Helicobacter pylori: the size of the problem. Gut. 1998; 43:S6-S9.
• [4]Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science. 1999; 284:1328-1333.
• [5]Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006; 19:449-490.
• [6]Hynes SO, Ferris JA, Szponar B, Wadstrom T, Fox JG, O'Rourke J et al.. Comparative chemical and biological characterization of the lipopolysaccharides of gastric and enterohepatic helicobacters. Helicobacter. 2004; 9:313-323.
• [7]Nielsen H, Birkholz S, Andersen LP, Moran AP. Neutrophil activation by Helicobacter pylori lipopolysaccharides. J Infect Dis. 1994; 170:135-139.
• [8]Perez-Perez GI, Shepherd VL, Morrow JD, Blaser MJ. Activation of human THP-1 cells and rat bone marrowderived macrophages by Helicobacter pylori lipopolysaccharide. Infect Immun. 1995; 63:1183-1187.
• [9]Yokota S, Amano K, Chiba S, Fujii N. Structures, biological activities and antigenic properties of Helicobacter pylori lipopolysaccharide. Recent Res Dev Microbiol. 2003; 7:251-267.
• [10]Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95:351-358.
• [11]de Boer WA. Helicobacter pylori infection: focus on a "search-and-treat" strategy for ulcer disease. Scand J Gastroenterol. 2000; 35 Suppl. 232:4-9.
• [12]Marshall BJ. Helicobacter pylori. Am J Gastroenterol. 1994; 89:S116-S128.
• [13]Piotrowski J, Piotrowski E, Skrodzka D, Slomiany BL, Slomiany A. Induction of acute gastritis and epithelial apoptosis by Helicobacter pylori lipopolysaccharide. Scand J Gastroenterol. 1997; 32:203-211.
• [14]Piotrowski J. Lipopolysaccharide a virulence factor of Helicobacter pylori. J Physiol Pharmacol. 1998; 49:3-24.
• [15]Stolte M, Edit S. Helicobacter pylori and the evolution of gastritis. Scand J Gastroenterol. 1996; 31 Suppl 214:13-16.
• [16]Fu S, Ramanujan KS, Wong A, Fantry GT, Drachenberg CB, James SP et al.. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase-2 in Helicobacter pylori gastritis. Gastroenterol. 1999; 116:1319-1329.
• [17]Gupta RA, Polk DB, Krishna U, Israel DA, Yan F, DuBois RN et al.. Activation of peroxisome proliferator-activated receptor suppresses nuclear factor kB-mediated apoptosis induced by Helicobacter pylori in gastric epithelial cells. J Biol Chem. 2001; 276:31059-31066.
• [18]Slomiany BL, Slomiany A. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric oxide synthase and gastric mucosal inflammatory responses to Helicobacterpylori lipopolysaccharide by peroxisome proliferator-activated receptor g activation. Inflammopharmacol. 2001; 8:371-382.
• [19]Moran AP. The role of lipopolysaccharide in Helicobacter pylori pathogenesis. Aliment Pharmacol Ther. 1996; 10 Suppl 1:39-50.
• [20]Piotrowski J, Majka J, Slomiany A, Slomiany BL. Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal somatostatin receptor. Int J Biochem Mol Biol. 1995; 36:491-498.
• [21]Bertrand S, Criscuolo F, Faivre B, Sorci G. Immune activation increases the susceptibility to oxidative tissue damage in zebra finches. Funct Ecol. 2006; 20:1022-1027.
• [22]Germano MP, Sanogo R, Guglielmo M, De Pasquale R, Crisafi G, Bisignano G. Effect of Pteleopsis suberosa extracts on experimental gastric ulcers and Helicobacter pylori growth. J Ethnopharmacol. 1998; 59:167-172.
• [23]Korman MG, Bolin TD, Engelmann JI, Pianko S. Sucralfate as an alternative to bismuth in quadruple therapy for Helicobacter pylori eradication. Helicobacter. 1997; 2:140-143.
• [24]Sezik E, Yesilada E, Tabata M, Honda G, Takaishi Y, Fujita T et al.. Traditional medicine in Turkey VIII. Folk medicine in east Anatolia; Erzurum, Erzincan, Agri, Kars, Igdir provinces. Econ Bot. 1997; 51:195-211.
• [25]Summary of WHO guidelines for the assessment of herbal medicines. Herbal Gram. 1993; 28:13-14.
• [26]Pertino M, Rodríguez JA, Theoduloz C, Razmilic I, Schmeda-Hirschmann G. Gastroprotective activity and cytotoxic effect of cyperenoic acid derivatives. J Pharm Pharmacol. 2006; 58:1507-1513.
• [27]Banerjee D, Maity B, Bauri AK, Bandyopadhyay SK, Chattopadhyay S. Gastroprotective properties of Myristica malabarica against indometacin-induced stomach ulceration: a mechanistic exploration. J Pharm Pharmacol. 2007; 59:1555-1565.
• [28]Lapa Fda R, Freitas CS, Baggio CH, Missau FC, Pizzolatti MG, Santos AR et al.. Gastroprotective activity of the hydroalcoholic extract obtained from Polygala paniculata L. in rats. J Pharm Pharmacol. 2007; 59:1413-1419.
• [29]Lemos M, de Barros MP, Sousa JP, da Silva Filho AA, Bastos JK, de Andrade SF. Baccharis dracunculifolia, the main botanical source of Brazilian green propolis, displays antiulcer activity. J Pharm Pharmacol. 2007; 59:603-608.
• [30]Rao CV, Vijayakumar M. Protective effect of (+)catechin against gastric mucosal injury induced by ischaemiareperfusion in rats. J Pharm Pharmacol. 2007; 59:1103-1107.
• [31]Pace GW, Leaf CD. The role of oxidative stress in HIV disease. Free Radic Biol Med. 1995; 19:523-528.
• [32]Chopra R. Indigenous drugs of India. Academic Publishers, Calcutta; 1982.
• [33]Shoba FG, Thomas M. Study of antidiarrhoeal activity of four medicinal plants in castor-oil induced diarrhoea. J Ethnopharmacol. 2001;76:73–6.
• [34]Das SK, Roy C. The protective role of Aegle marmelos on aspirin-induced gastro-duodenal ulceration in albino rat model: a possible involvement of antioxidants. Saudi J Gastroenterol. 2012; 18:188-94.
• [35]Singh P, Dutta SR, Guha D. Gastric mucosal protection by aegle marmelos against gastric mucosal damage: role of enterochromaffin cell and serotonin. Saudi J Gastroenterol. 2015; 21(1):35-42.
• [36]Okabe S, Takata Y, Takeuchi K, Naganuma T, Takagi K. Efects of carbenoxolone Na on acute and chronic gastric ulcer models in experimental animals. Am J Dig Dis. 1976; 21:618-625.
• [37]Slomiany BL, Piotrowski J, Slomiany A. Effect of sucralfate on gastric mucosal inflammatory responses induced by Helicobacter pylori lipopolysaccharide. Scand J Gastroenterol. 1998; 33:916-922.
• [38]Shay Komarov SA, Fels SS, Meranze D, Gruenstein M, Siplet H. A simple method for the uniform production of gastric ulceration. Gastroenterol. 1945; 5:43-55.
• [39]Card WI, Marks IN. The relationship between the acid output of the stomach following “maximal” histamine stimulation and the parietal cell mass. Clinical Science. 1960; 19:147-163.
• [40]Anson ML. The estimation of pepsin, trypsin, papain and cathepsin with haemoglobin. J Gen Physiol. 1938; 22:79-89.
• [41]Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with folin-phenol reagent. J Biol Chem. 1951; 193:265-275.
• [42]Misra HP, Fridovich I. The role of superoxide anion in the auto oxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972; 247:3170-3175.
• [43]Takahara S, Hamilton HB, Neel JV, Kobara TY, Ogura Y, Nishimura ET. Hypocatalasemia: a new genetic carrier state. J Clin Invest. 1960; 39:610-619.
• [44]Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973; 179:588-590.
• [45]Staal GE, Visser J, Veeger C. Purification and properties of glutathione reductase of human erythrocytes. Biochim Biophys Acta. 1969; 185:39-48.
• [46]Desai ID. Vitamin E, analysis methods for animal tissues. Methods Enzymol. 1984; 105:138-147.
• [47]Omaye ST, Turnbull JD, Sauberlich HE. Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol. 1979; 62:3-11.
• [48]Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82:70-77.
• [49]Habig WH, Pabst MJ, Jakoby WB. Glutathione-Stransferase. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974; 249:7130-7139.
• [50]Slomiany BL, Slomiany A. Role of ERK and p38 mitogen-activated protein kinase cascades in gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. IUBMB Life. 2001; 51:315-320.
• [51]Gschwantler M, Dragosics B. Physiopathology of Helicobacter pylori infection. Acta Med Austriaca. 2000; 27:117-121.
• [52]O'Toole D, Abdel-Latif MM, Long A, Windle HJ, Murphy AM, Bowie A et al.. Low pH and Helicobacter pylori increases nuclear factor kappa B binding in gastric epithelial cells: a common pathway for epithelial cell injury? J Cell Biochem. 2005; 96:589-598.
• [53]Kidd M, Miu K, Tang LH, Perez-Perez GI, Blaser MJ, Sandor A et al.. Helicobacter pylori lipopolysaccharide stimulates histamine release and DNA synthesis in rat enterochromaffin–like cells. Gastroenterol. 1997; 113:1110-1117.
• [54]Padol IT, Moran AP, Hunt RH. Effect of purified lipopolysaccharide from strains of Helicobacter pylori and Helicobacter felis on acid secretion in mouse gastric glands in vitro. Infect Immun. 2001; 69(6):3891-3896.
• [55]Durkin E, Moran AP, Hanson PJ. Apoptosis induction in gastric mucous cells in vitro: lesser potency of Helicobacter pylori than Escherichia coli lipopolysaccharide, but positive interaction with ibuprofen. J Endotoxin Res. 2006; 12:47-56.
• [56]Piotrowski J, Slomiany A, Slomiany B. Inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide. Int J Biochem Mol Biol. 1993; 31:1051-1058.
• [57]Slomiany BL, Liau YH, Lopez RA, Piotrowski J, Czajowski A, Slomiany A. Effect of Helicobacter pylori lipopolysaccharide on the synthesis of sulfated gastric mucin. Biochem Int. 1992; 27:687-697.
• [58]Veldhuyzen Van Zanten SJO, Dixon MF, Lee A. The gastric transitional zones: neglected links between gastroduodenal pathology and Helicobacter ecology. Gastroenterol. 1999; 116:1217-1229.
• [59]Nagashima R, Hoshino E, Hinohara Y, Sakai K, Hata S, Nakano H. Effect of sucralfate on ethanolinduced gastric mucosal damage in the rats. Scand J Gastroenterol. 1983; 18(3):17-20.
• [60]Mc Hardy GG. A multicentric double-blind trial of sucralfate and placebo in duodenal ulcer. J Clin Gastroenterol. 1981; 3(2):153-157.
• [61]Giesing DH, Bighley LD, Iles RL. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats. J Clin Gastroenterol. 1981; 3(2):111-116.
• [62]Steiner K, Bühring KU, Faro HP, Garbe A, Nowak H. Sucralfate: pharmacokinetics, metabolism and selective binding to experimental gastric and duodenal ulcers in animals. Arzneimittelforschung. 1982; 32:512-518.
• [63]Nagashima R. Mechanisms of action of sucralfate. J Clin Gastroenterol. 1981; 3(2):117-27.
• [64]Harrington SJ, Schlegel JF, Code CF. The protective effect of sucralfate on the gastric mucosa of rats. J Clin Gastroenterol. 1981; 3(2):129-34.
• [65]Hollander D, Tarnawski A, Gergely H, Zipser RD. Sucralfate protection of the gastric mucosa against ethanol-induced injury: a prostaglandin-mnediated process? Scand J Gastroenterol. 1984; 19(101):97-102.
• [66]Banerjee S, El-Omar E, Mowat A, Ardill JE, Park RH, Watson W et al.. Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50 % in patients with duodenal ulcer. Gastroenterol. 1996; 110:947-950.
• [67]Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis. 1990; 161:626-633.
• [68]Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med. 1995; 18:775-794.
• [69]Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N et al.. Helicobacter pylori infection and gastric carcinoma. N Engl J Med. 1991; 325:1127-1131.
• [70]Benhamida A, Man WK, Mcneil N, Spencer J. Histamine, xanthine oxidase generated oxygen derived free radicals and Helicobacter pylori in gastroduodenal inflammation and ulceration. Inflamm Res. 1998; 47:193-199.
• [71]Teshima S, Tsunawaki S, Rokutan K. Helicobacter pylori lipopolysaccharide enhances the expression of NADPH oxidase components in cultured guinea pig gastric mucosal cells. FEBS. 1999; 452:243-246.
• [72]Kim H. Oxidative stress in Helicobacter pylori-induced gastric cell injury. Inflammopharmacol. 2005; 13(1–3):63-74.
• [73]Ernst P. The role of inflammation in the pathogenesis of gastric cancer. Aliment Pharmacol Ther. 1999; 13 Suppl 1:13-18.
• [74]Dikshit BBL, Dutt S. Preliminary chemical examination of Aegle marmelos or the Indian Bel. J Ind Chem Soc. 1930; 7:759-764.
• [75]Parmar C, Kaushal MK. Aegle marmelos Correa. In: Wild Fruits of the Sub-Himalayan Region. Kalyani Publishers, New Delhi; 1982: p.1-5.
• [76]Roy SK, Khurdiya DS. Other Subtropical Fruit. Handbook of Fruit Science and Technology: Production, Composition, Storage and Processing. Salunkhe DK, Kadam SS, editors. Marcel Dekker, New York; 1995.
• [77]Arseculeratne SN, Gunatilaka AAL, Panabokke RG. Studies on medicinal plants of Srilanka: occurrence of pyrolizidine alkaloids and hepatotoxic properties in some traditional medicinal herbs. J Ethnopharmacol. 1981; 4:159-177.
• [78]Karunanayake EH, Welihinda J, Sirimanne SR, Sinnadorai G. Oral hypoglycaemic activity of some medicinal plants of Srilanka. J Ethnopharmacol. 1984; 11:223-231.
• [79]Nagaraju N, Rao KN. A survey of plant crude drugs of Rayalaseema, Andhra Pradesh India. J Ethnopharmacol. 1990; 29:137-158.
• [80]Singh YN. Traditional medicine in Fiji: Some herbal folk cures used by Fiji Indians. J Ethnopharmacol. 1986; 15:57-88.